Acutus Medical, Inc.
AFIBOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$5982
P/E Ratio—
52W High$0.014
52W Low$0.0001
Acutus Medical, Inc. (AFIB) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AFIB · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2025Report Date: Mar 24, 2025EPS Actual
-$0.05
Revenue
$0.01B
Fiscal Period
Q1 FY2025
FY ends December
Report Date
Mar 24, 2025
After Market Close
AFIB reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 7, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Aug 7, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Mar 30, 2026 | -$0.19 | — | — | — | $0.01B | — |
| ◌ Q2 FY2025 | Apr 3, 2025 | — | — | — | — | — | — |
| — Q1 FY2025 | Mar 24, 2025 | — | -$0.05 | — | $0.01B | — | — |
| — Q4 FY2024 | Nov 14, 2024 | — | -$0.03 | — | $0.01B | — | — |
| — Q3 FY2024 | Aug 8, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2024 | May 9, 2024 | — | -$0.07 | — | $0.00B | — | — |
Q3 FY2026
Aug 7, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Aug 7, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 30, 2026
EPS Actual
—
EPS Est.
-$0.19
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 3, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 24, 2025
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2024
Nov 14, 2024
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2024
Aug 8, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 9, 2024
EPS Actual
-$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Q3 FY2025 | $-0.20 | $-0.20 | $-0.20 | 1 |
| Q2 FY2025 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q1 FY2025 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q4 FY2024 | $-0.40 | $-0.40 | $-0.40 | 1 |
| Q3 FY2024 | $-0.41 | $-0.41 | $-0.41 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2025 | Mar 24, 2025 | — | $0.05 | $0.05 | +4.35% |
| — Q4 FY2024 | Nov 14, 2024 | — | $0.06 | $0.06 | +14.13% |
| — Q3 FY2024 | Aug 8, 2024 | — | $0.03 | $0.03 | +6.41% |
| — Q2 FY2024 | May 9, 2024 | — | $0.09 | $0.06 | -33.89% |
| ▼ Q2 FY2024 | Apr 1, 2024 | -193.1% | $0.19 | $0.18 | -4.26% |
| ▲ Q4 FY2023 | Nov 8, 2023 | +21.1% | $0.56 | $0.47 | -16.38% |
| ▼ Q3 FY2023 | Aug 7, 2023 | -3.3% | $0.69 | $0.68 | -2.03% |
| ▲ Q2 FY2023 | May 11, 2023 | +13.6% | $0.96 | $0.95 | -1.15% |
Q1 FY2025+4.35%
Report Date
Mar 24, 2025
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q4 FY2024+14.13%
Report Date
Nov 14, 2024
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Q3 FY2024+6.41%
Report Date
Aug 8, 2024
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q2 FY2024-33.89%
Report Date
May 9, 2024
EPS Beat/Miss
—
Price Before
$0.09
Price After
$0.06
Q2 FY2024-4.26%
Report Date
Apr 1, 2024
EPS Beat/Miss
-193.1%
Price Before
$0.19
Price After
$0.18
Q4 FY2023-16.38%
Report Date
Nov 8, 2023
EPS Beat/Miss
+21.1%
Price Before
$0.56
Price After
$0.47
Q3 FY2023-2.03%
Report Date
Aug 7, 2023
EPS Beat/Miss
-3.3%
Price Before
$0.69
Price After
$0.68
Q2 FY2023-1.15%
Report Date
May 11, 2023
EPS Beat/Miss
+13.6%
Price Before
$0.96
Price After
$0.95
Avg Beat Reaction-8.76%
Avg Miss Reaction-3.14%
Beat Rate2 / 8 quarters
Largest Move-33.89% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AFIB ends December
Acutus Medical, Inc. (AFIB) most recently reported earnings on March 24, 2025 for Q1 FY2025, posting EPS of $-0.05 (in line with the analyst consensus of —). The next AFIB earnings date is expected around September 1, 2026.
Each quarter, investors track AFIB earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AFIB revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AFIB's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AFIB earnings · 4 questionsAcutus Medical, Inc.'s next earnings report is expected around September 1, 2026. AFIB typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AFIB historically reports after market close (AMC).
AFIB earnings datewhen is AFIB earningsAFIB next earnings datewhen does AFIB report earningsAFIB earnings calendar
▸ Source: FMP · Acutus Medical, Inc. SEC filings · US GAAP · Acutus Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026